Firefly Neuroscience (AIFF) Depreciation & Amortization (CF) (2010 - 2026)
Firefly Neuroscience (AIFF) posted Depreciation & Amortization (CF) of $47000.0 for Q2 2026, up 4.44% on a QoQ basis from $45000.0 in Q1 2026, and up 9.3% year-over-year from $43000.0 in Q2 2025.
Analysis
Firefly Neuroscience (AIFF) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Firefly Neuroscience has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $47000.0 in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 9.3% year-over-year to $47000.0 in Q2 2026; TTM through Jun 2026 was $202000.0, a 188.57% increase from a year earlier, with the FY2025 full-year figure at $172000.0, up 156.72% from the prior year.
- Depreciation & Amortization (CF) was $47000.0 for Q2 2026 at Firefly Neuroscience, up from $45000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $58000.0 in Q3 2025, with the low at -$164471.0 in Q4 2023.
- Average Depreciation & Amortization (CF) over 5 years is $30999.1, with a median of $52695.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) tumbled 403.36% in 2023, then surged 975.0% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $54216.0 in 2022, then sank by 403.36% to -$164471.0 in 2023, then surged by 104.86% to $8000.0 in 2024, then jumped by 550.0% to $52000.0 in 2025, then slipped by 9.62% to $47000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $47000.0 (Q2 2026), $45000.0 (Q1 2026), and $52000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 389,000.00 |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 29.40 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | - |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 116.70 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 245,000.00 |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | - |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | 47,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47,000.00 |
| Mar 31, 2026 | 45,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Dec 31, 2023 | -164,471.00 |
| Sep 30, 2023 | 56,644.00 |
| Jun 30, 2023 | 53,669.00 |
| Mar 31, 2023 | 54,158.00 |
| Dec 31, 2022 | 54,216.00 |
| Sep 30, 2022 | 53,390.00 |
| Jun 30, 2022 | 54,867.00 |
| Mar 31, 2022 | 57,513.00 |
| Dec 31, 2021 | 125,475.00 |
| Sep 30, 2021 | 55,150.00 |
| Jun 30, 2021 | 50,590.00 |
| Mar 31, 2021 | 5,383.00 |